Early stage triple negative breast cancer (TNBC) requires a tailored treatment approach due to its unique characteristics.

Treatment Options Overview

• Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Clinical Trials

Surgery

Surgery is often the first line of treatment for early stage TNBC. It can involve:

• Lumpectomy: Removing the tumor and a small margin of surrounding tissue.
• Mastectomy: Removing one or both breasts, depending on the extent of the disease.

Chemotherapy

Chemotherapy is a critical component of treatment for TNBC. It aims to kill cancer cells and reduce the risk of recurrence. Typical regimens include:

• Adriamycin (doxorubicin) and Cyclophosphamide
• Taxanes (e.g., Paclitaxel)

Radiation Therapy

Radiation therapy is usually recommended after surgery to target any remaining cancer cells, especially if a lumpectomy was performed.

Targeted Therapy

Currently, there are limited options for targeted therapy specifically for TNBC. However, studies are ongoing to find effective agents.

Clinical Trials

Participation in clinical trials can provide access to cutting-edge therapies and contribute to advancements in TNBC treatment.

Statistical Data

Mind Map of Treatment Options

1. Early Stage Triple Negative Breast Cancer
├── 2. Surgery
| ├── Lumpectomy
| └── Mastectomy
├── 3. Chemotherapy
| ├── Adriamycin
| └── Taxanes
├── 4. Radiation Therapy
├── 5. Targeted Therapy
└── 6. Clinical Trials